Skip to main content

Hot and Cold Therapy Packs Market to Grow With Increasing Prevalence of Chronic Pain

 


Market Overview:

Heat and cold therapy is a non-invasive and non-addictive pain relief therapy used for muscle relaxation, reducing swelling, and improving blood circulation. It is the most effective, cheap, and rapid relief treatment therapy. Heat therapy can utilize heat pads, hot water bottles, or warm baths. Cold therapy involves ice packs, cold compresses, or cool water. In some cases, using both may be a successful combination. Heat boosts the flow of blood and nutrients to an area of the body. It works best for morning stiffness or to warm up muscles before activity. Whereas, cold slows blood flow and reduce pain and swelling. It's often best for short-term pain, like that from a strain or a sprain. Heat and cold therapy packs are often recommended to help relieve an aching pain that results from muscle or joint damage.

Increasing adoption of non-surgical and non-pharmaceutical pain relive management therapies is expected to boost growth of the hot and cold therapy packs market

According to World Health Organization (WHO) 2015, approximately 8 million individuals face minor accidents, every day. Thus, minimal injuries due to accidents and its treatments to relieve the pain are factors expected to fuel the hot and coldtherapy packs market growth. Moreover, according to the Arthritis Foundation, cold packs are best for severe pain in body parts whereas, heat treatment such as warm baths and heating pads are likely to aid in relaxing stiff joints and muscles.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more